FBLG vs. ORGO, AMRN, PGEN, VRCA, ANRO, SKYE, NBTX, VTYX, ACIU, and TERN
Should you be buying FibroBiologics stock or one of its competitors? The main competitors of FibroBiologics include Organogenesis (ORGO), Amarin (AMRN), Precigen (PGEN), Verrica Pharmaceuticals (VRCA), Alto Neuroscience (ANRO), Skye Bioscience (SKYE), Nanobiotix (NBTX), Ventyx Biosciences (VTYX), AC Immune (ACIU), and Terns Pharmaceuticals (TERN). These companies are all part of the "pharmaceutical preparations" industry.
FibroBiologics (NASDAQ:FBLG) and Organogenesis (NASDAQ:ORGO) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, profitability, media sentiment, institutional ownership, community ranking and earnings.
Organogenesis has higher revenue and earnings than FibroBiologics.
Organogenesis has a net margin of 1.34% compared to FibroBiologics' net margin of 0.00%. Organogenesis' return on equity of 2.11% beat FibroBiologics' return on equity.
Organogenesis has a consensus price target of $4.83, indicating a potential upside of 83.78%. Given Organogenesis' higher possible upside, analysts clearly believe Organogenesis is more favorable than FibroBiologics.
Organogenesis received 96 more outperform votes than FibroBiologics when rated by MarketBeat users.
In the previous week, FibroBiologics and FibroBiologics both had 2 articles in the media. FibroBiologics' average media sentiment score of 1.87 equaled Organogenesis'average media sentiment score.
49.6% of Organogenesis shares are owned by institutional investors. 34.0% of Organogenesis shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Summary
Organogenesis beats FibroBiologics on 10 of the 10 factors compared between the two stocks.
Get FibroBiologics News Delivered to You Automatically
Sign up to receive the latest news and ratings for FBLG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding FBLG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
FibroBiologics Competitors List
Related Companies and Tools
